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Extracranial carotid aneurysm is a rare vascular manifestation of Behçet disease. To our knowledge, only 32 cases have
been reported. This article presents a complex case of a 28-year-oldmanwhowas first treated by vein graft reconstruction.
At 12 months of follow-up, a nonanastomotic false aneurysm of the vein graft occurred and was treated by interposition
of prosthetic graft. Twomonths later, an anastomotic pseudoaneurysm between the two grafts was excluded by two stent
grafts. Based on our experience and a review of the literature, we compared the outcomes of prosthetic and autologous
vein reconstructions and discussed the role of carotid ligation and immunosuppressive treatment. (J Vasc Surg 2010;52:
471-4.)Behçet disease is a rare systemic vasculitis, characterized
by recurrent oral and genital aphthae, skin lesions, and
ocular manifestations. Vascular manifestations are com-
mon, with venous thrombophlebitis being most frequent,
followed by arterial aneurysm and occlusion. Aneurysms
occur preferentially in the abdominal aorta and pulmonary
arteries.1 To our knowledge, only 32 cases of extracranial
carotid aneurysm have been reported.2-21 Since the main
vascular manifestation of Behçet disease is thrombophlebi-
tis, prosthetic grafts8-14 are preferred to autologous vein
grafts5,15,17 for treatment of carotid aneurysm. This article
describes a complex case treated by vein graft reconstruc-
tion but requiring several reoperations. Based on our expe-
rience and a review of the literature, we compared the
outcomes of both reconstructions and discussed the role of
carotid ligation and immunosuppressive treatment.
CASE REPORT
A 28-year-old West Indian man was admitted for a mass
ongoing in the neck for 3 weeks. He had a 2-year history of
recurrent oral aphthae and folliculitis. Physical examination re-
vealed a pulsating mass in the right cervical region with severe
folliculitis of the overlying skin. The patient’s temperature was
38°C. Neurologic and ophthalmic examination revealed no abnor-
mality. Blood tests showed a C-reactive protein level at 28.7
mg/dL (normal, 5 mg/L) with white blood cell count of
13.2/L. Computed tomography (CT) scan depicted a contained
rupture of a 4 cm sacciform aneurysm in the right common carotid
artery (CCA) immediately proximal to the carotid bifurcation.
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doi:10.1016/j.jvs.2010.03.028Surgery was performed immediately to prevent rupture. The
CCA and internal carotid artery (ICA) were controlled and
clamped. The aneurysm was then opened, and the external carotid
artery (ECA) was occluded using a balloon catheter. Because of
folliculitis, continuity between the CCA and ICA was restored by
interposing an apparently healthy saphenous vein harvested from
the thigh. The ECA was ligated. No postoperative complications
occurred, and the patient was discharged on the 10th postopera-
tive day.
Examination of biopsy specimens collected from the carotid
and surrounding zones showed no infection, but did show
destruction of the media and intima due to lymphocyte infiltra-
tion. Tests for HLA B51, autoimmune antibodies (serum anti-
nuclear, anticardiolipin, and antineutrophil cytoplasmic anti-
bodies), and infectious disease (human deficiency virus,
hepatitis B and C virus, and syphilis) were negative. Based on
case history, the diagnosis of Behçet disease was made. The
patient was prescribed aspirin 160 mg/day and colchicine 1
mg/day. Ultrasonography at 6 months showed a patent graft
and the patient remained symptom-free for 1 year.
Twelve months after intervention, the patient was referred to
our institution for right cervical pain. Physical examination showed
no abnormality except swelling in the right cervical region and oral
aphtae. CT scan revealed a nonanastomotic 3 cm vein graft pseu-
doaneurysm (Fig 1). The patient was rapidly transferred to the
operating room. The dissection of the distal anstomosis between
the ICA and vein graft was difficult due to inflammatory tissue.
After cross-clamping the CCA and vein graft distally, the pseudo-
aneurysm was opened, and a defect 1 cm in diameter was identified
in the vein wall (Fig 2). A polytetrafluroethylene (PTFE) graft was
implanted between the CCA and healthy distal part vein graft.
Microscopic examination of the vein showed intima and media
destruction. The patient was discharged without complications
and prednisone 20 mg/day was associated with colchicine and
aspirin. Routine clinical and ultrasonography findings at 2 months
were normal.
Three months after reoperation, the patient was readmitted
for a pulsatile right cervical mass that developed suddenly after
sneezing. At that time, oral aphtae reappeared for 5 days. Just
before iodine injection for CT scan, the mass suddenly expanded,
and blood pressure dropped. Emergency endovascular exclusion
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second reoperation). Selective angiography via a femoral access
(Fig 3) revealed a pseudo-aneurysm at the anastomosis between
the remaining vein graft and PTFE graft. A 0.25 Terumo guide-
wire was placed distally in the ICA. Overlapping Hemobahn (W. L.
Gore, Flagstaff, Ariz) stent-grafts (distal, 5 cm 9 mm; proximal,
5 cm  11 mm) were deployed in the remaining vein graft
(diameter, 10 mm), so as to cover the proximal end of the ICA and
distal end of the PTFE graft, respectively. Completion arteriogra-
phy (Fig 3) showed complete exclusion of the pseudo-aneurysm
and a patent ICA. Postoperative recovery was uneventful. Prior to
discharge on day 9, CT scan showed stent graft occlusion but no
ischemic brain lesions. Since neurologic examination was normal,
Fig 1. Computed tomography scan of the ruptured vein graft.
Arrowheads indicate proximal and distal ends of the vein graft.
Asterix shows external carotid artery previously ligated.
Fig 2. Operative view of vein graft rupture after vessel loop
control of common carotid artery (CCA) proximally and clamp
control of the vein graft distally.the patient was discharged. Prescribed medication included aspirin160 mg/day, colchicine 1 mg/day, prednisone 80 mg/day, and
azathioprine 150 mg/day. Twelve months after the stenting, the
patient was asymptomatic, and ultrasonography showed no aneu-
rysm at other locations.
DISCUSSION
Since the main vascular manifestation of Behçet dis-
ease is thrombophlebitis, prosthetic grafts are preferred
to autogenous vein for treatment of carotid aneurysm
(Table I). Only one9 out of eight prosthetic grafts8-14
occluded, but three out of six autologous venous recon-
structions,5,15,17 including our case, failed.5,17 Despite
suspicion of Behçet disease in our case, we decided against
use of prosthetic material due to presence of folliculitis. To
our knowledge, this is the first report describing venous
graft rupture in a nonanastomotic site. This suggests that
vasculitis can involve venous tissue and supports preferen-
tial use of prosthetic grafts.13,21 Suturing with wide bites in
vessel segments away from the diseased artery may lower
the risk of pseudoaneurysm after both prosthetic and au-
togenous reconstruction.22 In our patient, dissection of the
distal vein graft during the first reoperation was difficult,
but we identified a presumably “healthy” segment for
anastomosis of the PTFE graft. The presence of inflamma-
tion should have led us to suspect a diseased vein wall. It is
also for this reason that simple patch closure of the arterial
wall defect7 is not recommended.
As suggested previously,16-20 management of aneurysm
in Behçet disease may benefit from endovascular techniques.
Fig 3. A: Diagnostic angiogram showing pseudoaneurysm at anas-
tomosis between the PTFE and vein graft.B:Completion angiogram
after deployment of two overlapping stent grafts. *, anastomosis
between the common carotid artery and PTFE graft; single arrow-
heads, proximal and distal ends of the remaining vein graft; double
arrowheads, proximal and distal ends of the stent grafts.Indeed, stenting would eliminate the risk of anastomotic
A, co
ds.
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is available. Occlusion occurred in two of the four reported
cases of endovascular treatment using poorly-flexible first-
generation balloon-expandable covered stent grafts.17,18 In
our patient, because of the hazardous proximal control due to
massive hematoma at the base of the neck, and the impossi-
bility of dissecting the distal part of the vein graft during
previous reoperation, we preferred endovascular treatment to
ligation. The 11-mm proximal stent graft was oversized in
relation to the 8-mm PTFE graft. However, we had already
used our last 9-mm stent graft distally. This problem illustrates
the difficulties associated with emergency treatment (ie, insuf-
ficient time for sizing based on CT scan reconstruction and for
ordering appropriately sized stent grafts). Asymptomatic oc-
clusion of our stent graft suggests that particular attention is
Table I. Clinical findings in case reported herein and 24 p
extracranial carotid aneurysm due to Behçet disease
Study
Age (y)/
Gender Localization Treatmen
Park (2) 25/F Bilateral CCA Not described
Canova (3) 32/M ICA Not described
Dhobb (4) 44/F ICA Resection and
to-end anast
Sayed (5) 21/M CCA Resection and
to-end anast
Sayed (5) 30/M CCA Direct suture
Antar (6) 13/M CCA 1. Direct sutur
2. Ligation
Sasaki (7) 16/M CCA 1. PTFE patch
2. Ligation
Suzuki (8) 16/M CCA PTFE bypass
Tacal (9) 35/M ICA Tube grafting
Kuzu (10) ? ? PTFE bypass
Tuzuner (11) 16/M CCA PTFE bypass
Özyazıcıoglu (12) 34/F CCA (iatrogenic
puncture)
PTFE bypass
Iscan (13) 43/M ICA PTFE bypass
Bouarhroum (14) 26/M CCA PTFE bypass
Bouarhroum (14) 41/M CCA PTFE bypass
Posacioglu (15) 31/M CCA Vein graft
Sayed (5) 31/M Bifurcation Vein graft
Sayed (5) 35/M ICA 1. Vein graft
2. Ligation
Sayed (5) 30/M ICA Vein graft
Bonnotte (16) 47/M ICA Bare stent, coi
embolization
Park (17) 32/M CCA (previously
vein grafted)
Stent graft (Jo
Jomed)
Kwon Koo (18) 32/M CCA Stent graft (Jo
Jomed)
Caballol (19) 29/M ICA Stent graft (W
Boston)
Ohshima (20) 56/M ICA Stent-graft (Pa
Boston) coil
embolization
Berard et al
(current study)
28/M CCA Vein graft
PTFE graft
Stentgraft
AAA, Abdominal aortic aneurysm; AZT, azathioprine; CC, colchicine; CC
internal carotid artery; mo, month; PTFE, polytetrafluoroethylene; S, steroinecessary with regard to carotid artery ligation. However,postoperative follow-up in three previous cases 6,7,21 and in an
eight-patient report5 involving ligation (Tables I and II) were
uneventful, except in one case of secondary ligation to treat
pseudoaneurysm complicating primary vein grafting.5 In their
series, Sayed et al5 proposed ligation if stump pressure 70
mm Hg and demonstrated that this option appears to be a
reasonable alterative in high-risk surgical patients.
Medical treatment is a keystone for management of vas-
cular manifestations of Behçet disease.22,23 In our case, occur-
rence of acute oral ulcerations in all three management epi-
sodes suggests that medical treatment was ineffective. Vein
rupture and anastomotic pseudo-aneurysm occurred despite
therapy using colchicine alone and colchicine plus corticoste-
roids, respectively. The European League Against Rhumatism
recommendations suggest that immunosuppressors lower the
usly reported cases of vascular reconstruction to treat
Preop
medic
Postop
medic
Status
(Follow-up)
? ? ?
? ? Alive and well (11 mo)
is
? ? Patent (12 mo)
is
S  CPP CPP  CC Died from ruptured
pulmonary aneurysm
(2 mo)
S  CPP CPP  CC Alive (?)
?
?
?
S  CHB
Pseudoaneurysm? (3 mo)
Alive (48 mo), AAA reported
?
?
?
?
Pseudoaneurysm (2 mo) alive
(3 mo)
No S Patent (24 mo)
? ? Occluded (2 weeks)
? ? Alive (?)
CC  S CC Patent (84 mo)
No AZT  S ?
? ? Patent (35 mo)
No S Patent (12 mo)
No S Patent (11 mo)
No Not detailed Patent (16 mo)
S  CPP CPP  CC Patent (?)
S  CPP
CC
CPP  CC
CPP  CC
Pseudoaneurysm (6 mo)
Alive but minor stroke (?)
S  CPP CPP  CC Patent (?)
CC AZT No complication (48 mo)
? ? Occluded (6 mo)
? S  AZT Occluded (41 mo)
ft, S  AZT S  AZT Patent (27 mo)
r, ? S  AZT Patent (12 mo)
No
CC
S  CC
CC
S  CC
S  CC  AZT
Ruptured (12 mo)
Pseudoaneurysm (3 mo)
Occlusion (9 days)
mmon carotid artery; CHB, chlorambucil; CPP, cyclophosphamide; ICA,revio
t
end-
omos
end-
omos
e
l
stent,
stent,
allgra
ssagerecurrence risk and propose cyclophosphamide and cortico-
A, in
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the optimal dose and duration of the therapy are still in
question.23 As proposed by many authors (Tables I and II),
preoperative immunosuppression should be initiated immedi-
ately, but postponing the intervention is not always feasible,
especially in symptomatic aneurysms.5,13
In summary, analysis of the literature and our report has
four main implications for treatment of carotid aneurysm in
BD. First, synthetic grafts should be preferred to autoge-
nous grafts. Second, endovascular exclusion based on care-
ful CT scan vessel sizing appears to be a promising option,
but further study is needed to assess long-term benefits.
Third, ligature should be considered in case of intraopera-
tive difficulty. Fourth, aggressive postoperative immuno-
suppessive therapy is necessary to control disease activity.
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primary ligation to treat extracranial carotid aneurysm
Preop medic Postop medic Status (Follow-up)
n ? CPP Alive (1 mo)
n S  CPP CPP  CC Died from cardiomyopathy
(4 mo)
n S  CPP CPP  CC Alive (?)
n S  CPP CPP  CC Alive (?)
n S  CPP CPP  CC Alive (?)
n No CPP  CC Alive (?)
n S  CPP CPP  CC Alive (?)
n S  CPP CPP  CC Alive (?)
ternal carotid artery; mo, month; S, steroids.es of
ent
gatio
gatio
gatio
gatio
gatio
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